Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Does serum Gas6 level change in active uveitis? | Ther Adv Ophthalmol | 2025 | 40151682 | PubTator, text mining | PubMed |
| Interrogating mediators of single-cell transcriptional changes in the acute damaged cerebral cortex: Insights into endothelial-astrocyte interactions. | Mol Cell Neurosci | 2025 | 40090391 | PubTator, text mining | PubMed |
| Vitamin K supports TGF-β1 depended in vitro human Langerhans cell differentiation and function via Axl. | Front Immunol | 2025 | 40040711 | PubTator, text mining | PubMed |
| Adipose-derived stem cells attenuate rheumatoid arthritis by restoring CX3CR1+ synovial lining macrophage barrier. | Stem Cell Res Ther | 2025 | 40038808 | PubTator, text mining | PubMed |
| Red blood cells-derived components as biomimetic functional materials: Matching versatile delivery strategies based on structure and function. | Bioact Mater | 2025 | 40034412 | PubTator, text mining | PubMed |
| Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression. | Genes Dev | 2025 | 40015991 | PubTator, text mining | PubMed |
| 3D bioprinting lobule-like hepatorganoids with induced vascularization for orthotopic implantation. | Mater Today Bio | 2025 | 39911370 | PubTator, text mining | PubMed |
| AXL-Mediated Drug Resistance in ALK-Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts. | Cancer Sci | 2025 | 39904499 | PubTator, text mining | PubMed |
| Activated AXL Ameliorates Alcohol-associated Steatotic Liver Ischemia-Reperfusion Injury by Inhibiting ER stress and Mitochondria-associated Apoptosis. | Int J Biol Sci | 2025 | 39897049 | PubTator, text mining | PubMed |
| New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis. | J Pharmacol Exp Ther | 2025 | 39892997 | PubTator, text mining | PubMed |
| Distinct TYRO3 and PROS1 expression levels contribute to preeclampsia pathogenesis. | Histochem Cell Biol | 2025 | 39878883 | PubTator, text mining | PubMed |
| Vitamin K1 Administration Increases the Level of Circulating Carboxylated Osteocalcin in Critically Ill Patients. | Nutrients | 2025 | 39861478 | PubTator, text mining | PubMed |
| Bisecting GlcNAc modification of vesicular GAS6 regulates CAFs activation and breast cancer metastasis. | Cell Commun Signal | 2025 | 39844194 | PubTator, text mining | PubMed |
| Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation. | Eur Respir J | 2025 | 39788632 | PubTator, text mining | PubMed |
| Mangiferin Attenuates Myocardial Ischemia Reperfusion Injury by Regulating the GAS6/Axl Signaling Pathway. | Phytother Res | 2025 | 39780746 | PubTator, text mining | PubMed |
| Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice. | J Clin Invest | 2025 | 39774471 | PubTator, text mining | PubMed |
| Comprehensive analysis of scRNA-seq and bulk RNA-seq reveals the non-cardiomyocytes heterogeneity and novel cell populations in dilated cardiomyopathy. | J Transl Med | 2025 | 39762897 | PubTator, text mining | PubMed |
| Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients. | Mol Neurobiol | 2025 | 39762711 | PubTator, text mining | PubMed |
| Incorporation of a rigid 1,3-diketone-containing fragment led to significantly improved AXL inhibitory activity: design, synthesis, and SAR of the anilinopyrimidine AXL inhibitors. | Mol Divers | 2025 | 39731692 | PubTator, text mining | PubMed |
| Bone metastasis in endocrine-related cancer: unravelling invasion and destruction. | Endocr Relat Cancer | 2025 | 39699130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=9